Insights & Resources – COD Research

Medical Affairs

CT Quality Assurance

Clinical Services

Biometrics

Transforming Complexity into Success: A Large-Scale Global Phase III Biosimilar Dermatology Trial

Strategic Planning for Patient Recruitment

Pulmonary Disease Introduction: Prevalence, Causes, Prevention & Treatment

EMA
FDA
MHRA

PSUSA/00000078/202601
Source: EMA Published on 2026-10-21
Human medicines European public assessment report (EPAR): GONAL-f, follitropin alfa, Date of authorisation: 20/10/1995, Revision: 28, Status: Authorised
Source: EMA Published on 2026-10-21
Human medicines European public assessment report (EPAR): Rayvow, lasmiditan, Date of authorisation: 17/08/2022, Revision: 7, Status: Authorised
Source: EMA Published on 2026-10-21
Minutes - Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 23 September 2026
Source: EMA Published on 2026-10-21
Agenda - HMA / EMA multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations
Source: EMA Published on 2026-10-21
CHMP PROM minutes for the meeting on 19 January 2026
Source: EMA Published on 2026-10-21

Read More